5ÔÂ22ÈÕ£¬ng28ÄϹ¬ÒÑÏòÓ¢¹úÒ½Ò©ºÍ½¡¿µ²úÆ·ÖÎÀí¾Ö£¨MHRA£©Ìá½»ÁËLecanemabµÄÉÏÊÐÐí¿ÉÉêÇ루MAA£©¡£LecanemabÊÇÒ»ÖÖʵÑéÐÔ¿¹µí·ÛÑùÂѰצ£¨A¦Â£©ÔÏËά¿¹Ì壬ÓÃÓÚÖÎÁÆ´óÄÔÖÐÈ·Èϱ£´æµí·ÛÑùÂѰײ¡ÀíµÄÔçÆÚ°¢¶û´Äº£Ä¬²¡£¨AD£©ºÍÇá¶ÈADÒýÆðµÄÈÏÖªÕÏ°¡£LecanemabÒѱ»MHRAÖ¸¶¨ÎªILAP*¡£
»ùÓÚÑéÖ¤ÐÔIIIÆÚClarity ADÑо¿ºÍIIbÆÚÁÙ´²Ñо¿£¨study 201£©µÄ½á¹ûÌá½»MAAÉêÇë¡£¸Ã½á¹û±êÃ÷£¬Í¨¹ýLecanemabÖÎÁÆ¿ÉÒÔ¼õÉÙÔçÆÚADµÄÁÙ´²Ë¥ÍË£¬µ«MHRAÊÇ·ñ½ÓÊÜÕâЩÑо¿½á¹û£¬ÔòÐèÒª½øÒ»²½µÄÑéÖ¤¡£Clarity ADÑо¿µÖ´ïÁËÖ÷ÒªÖÕµãºÍËùÓÐÒªº¦´ÎÒªÖյ㣬½á¹û¾ßÓÐÏÔÖøͳ¼ÆѧÒâÒå¡£LecanemabÑ¡ÔñÐԵؽáºÏ²¢Ïû³ý¿ÉÈÜÇÒÓж¾µÄA¦Â¾Û¼¯Ì壨ÔÏËά£©£¬ÓÐÖúÓÚ¼õ»ºADµÄÉñ¾¶¾ÐÔ¡£Òò´Ë£¬Lecanemab¿ÉÄܶԼ²²¡²¡ÀíºÍ¼²²¡½ø³ÌÓÐDZÔÚµÄÓ°Ïì¡£
LecanemabµÄÈ«Çò¿ª·¢ºÍ×¢²áÉêÇëÓÉng28ÄϹ¬Ö÷µ¼£¬¶ø²úÆ·ÔòÓÉng28ÄϹ¬ºÍ²³½¡ÅäºÏ½øÐÐÉÌÒµ»¯ºÍÍƹ㡣ng28ÄϹ¬ÓµÓÐ×îÖÕ¾ö²ßȨ¡£
*ILAPÊÇÓ¢¹úMHRAΪÐÂÏîÄ¿¿ª·¢ÌṩµÄÒ»¸ö;¾¶£¬ÆäÄ¿±êÊÇËõ¶ÌÁ¢ÒìÒ©ÎïÉÏÊÐʱ¼ä£¬ÒÔÖÎÁÆΣ¼°ÉúÃü¡¢ÑÏÖØË¥ÈõµÄ¼²²¡ºÍ/»ò»¼ÕßÐèÇóÏÔÖøδ»ñµÃÂú×ãµÄ¼²²¡¡£ILAPÖ¼ÔÚͨ¹ýÔöÇ¿ÉêÇëÕß¡¢MHRAºÍ±¨Ïú»ú¹¹£¨NICE£©Ö®¼äµÄе÷À´ÊµÏÖÕâһĿ±ê£¬ÎªÉÏÊÐÐí¿ÉÉêÇ루MAA£©µÄÌá½»×öºÃ×¼±¸£¬ÒÔÖ§³Ö¼ÓËÙ×¼Èë¡£